Airway MUC2 is decreased in patients with severe COPD and bacterial colonization
L. Garcia-Bellmunt, E. F. Mateus, J. Giner, I. Solanes, A. Torrego, D. Castillo, A. Crespo, B. G. Cosío, E. Sala, M. I. Restrepo, A. Anzueto, V. Plaza, O. Sibila (Barcelona, Mallorca, Spain; San Antonio, United States Of America)
Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections
Session: Pathogenesis and mechanisms of respiratory infections
Session type: Poster Discussion
Number: 4945
Disease area: Airway diseases, Respiratory infections
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Garcia-Bellmunt, E. F. Mateus, J. Giner, I. Solanes, A. Torrego, D. Castillo, A. Crespo, B. G. Cosío, E. Sala, M. I. Restrepo, A. Anzueto, V. Plaza, O. Sibila (Barcelona, Mallorca, Spain; San Antonio, United States Of America). Airway MUC2 is decreased in patients with severe COPD and bacterial colonization. Eur Respir J 2014; 44: Suppl. 58, 4945
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
COPD and pseudomonas aeruginosa , an association Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections Year: 2014
Bacterial and viral microbiomes in COPD exacerbations of unidentified cause Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections Year: 2014
High mortality in COPD patients with isolation of aspergillus spp in bronchial secretions Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013
Relationship between procacitonin and C-reactive protein and sputum culture results in patients with acute excecerbation of COPD Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014
Etiological structure from sputum of patients with exacerbation of COPD Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections Year: 2014
Antimicrobial profile and bacterial resistance in patients wit acute exacerbation of COPD, an Upper Egypt multicenters experience Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013
Bacterial colonization in patients with bronchiectasis Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections Year: 2014
Factors contributing to severe pneumonia in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014
Identification of nasal virus infection in patients with COPD exacerbations Source: International Congress 2014 – COPD: points to ponder Year: 2014
The outcome of community-acquired pneumonia in patients with COPD, asthma and ILD - a case-control study Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014
Immunoglobulin G subclass deficiency in adult patients with chronic obstructive lung diseases Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections Year: 2014
LATE-BREAKING ABSTRACT: The Guangzhou COPD exacerbation study: relationship of exacerbations with viral infections and soluble biomarkers Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014
Genetic determinants of oropharyngeal streptococci antimicrobial resistance in COPD patients and asthma sufferers Source: International Congress 2015 – Advances from translational research in respiratory infections Year: 2015
Tiotropium attenuates pulmonary inflammation in a novel mouse smoke RSV re-infection model Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections Year: 2014
Association of bronchial hyperresponsiveness and acute respiratory viral infections (ARVI) Source: Annual Congress 2013 –Interesting cases of respiratory infections Year: 2013
Vitamin D levels in patients with non-CF bronchiectasis Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014
Pulmonary nocardiosis (PN) complicating chronic pulmonary diseases Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014
Spectrum of viral pathogens in adults patients with infectious exacerbations of bronchial asthma Source: Annual Congress 2013 –Viral infections Year: 2013
Effect of long term azithromycin on exacerbations in non CF bronchiectasis Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014
Microbial aetiology of community-acquired pneumonia and it's relation with ICS use in patients with COPD – Results from the German competence network CAPNETZ Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014